BECTON DICKINSON & CO — Director's Dealing 2023

Nov 29, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2023-11-26

Reporting Person: Hickey David (EVP & President, Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-26	Common Stock	A	1663	$0.0	Acquired	5862	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-26	Stock Appreciation Rights	$238.89	A	9213	Acquired	2033-11-26	Common Stock (9213)	Direct
2023-11-26	Rights to Common Stock Under Deferred Compensation Plan	$238.89	A	3024	Acquired		Common Stock (3024)	Direct

Footnotes

F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2: The stock appreciation rights vest in four annual installments beginning November 26, 2024.

F3: The securities are distributed following termination of the reporting person's employment or on the date or dates specified by the reporting person.